Resilient Pharmaceuticals

Resilient Pharmaceuticals
FormerlyLykos Therapeutics; MAPS Public Benefit Corporation; MAPS PBC
TypePublic benefit corporation
IndustryPharmaceutical; Psychedelic medicine
Founded2014 (2014)
Headquarters
United States Edit this on Wikidata
Websitelykospbc.com

Resilient Pharmaceuticals, formerly known as Lykos Therapeutics and before that as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) developing MDMA ("ecstasy") for potential medicinal use. It was founded and is part-owned by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS PBC was founded in 2014 and was renamed to Lykos Therapeutics in January 2024, then to Resilient Pharmaceuticals in August 2025.